Brighton Jones LLC Citius Pharmaceuticals, Inc. Transaction History

Brighton Jones LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.88 - $1.87 $8,800 - $18,700	-10,000 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$1.51 - $2.2 $30,200 - $44,000	-20,000 Reduced 66.67%	10,000 $15,000
Q2 2021 Aug 10, 2021	BUY	$1.51 - $4.23 $30,200 - $84,600	20,000 Added 200.0%	30,000 $104,000
Q1 2021 May 07, 2021	BUY	$1.04 - $2.34 $10,400 - $23,400	10,000 New	10,000 $18,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $376M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.